How to buy Spinal Elements (SPEL) stock

Spinal Elements is expected to go public soon. Here's what we know about the IPO — and how to buy Spinal Elements stock when it's available.

What we know about the Spinal Elements IPO

Spinal Elements filed a registration form with the US Securities and Exchange Commission (SEC) to go public on the Nasdaq Global Select Market under the ticker symbol SPEL. Not yet an official IPO, this is one of the first steps of taking a private company public.

The exact IPO date has not been announced. Stocks are expected to open at a price of between $13.00 and $15.00. We'll update this page with more information as it becomes available.

How to buy Spinal Elements stock when it starts trading

Once Spinal Elements goes public, you'll need a brokerage account to invest. Consider opening a brokerage account today so you're ready as soon as the stock hits the market.

Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
Open your brokerage account. Complete an application with your details.
Confirm your payment details. Fund your account.
Research the stock. Find the stock by name or ticker symbol – SPEL – and research it before deciding if it's a good investment for you.
Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.

Finder's picks for buying Spinal Elements stock when it goes public

Go to site

Commission-free stock trading

No-cost financial planning and automated investing
$0 commission on stocks, ETFs and options
Get up to $1,000 in stock when you fund a new account within 30 days

Go to site

$200 in US stocks

Trade options, futures, options on futures, stocks, ETFs
$0 commission to close options
Get $100-$5,000 when you open an account with $5,000 to $1,000,000+

Go to site

Easy access to diverse assets

Trade stocks, bonds, options, ETFs, crypto, Treasurys, collectibles, royalties
Earn 5.1% APY on your cash
Earn a $0.18 rebate on options, with no commissions and no per-contract fees

How do similar companies perform?

It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. Looking at the performance of similar companies can help you decide if now is a good time to buy Spinal Elements stock.

See how the following stocks are performing, and view details like market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield.

Company summary
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Historical performance
Stock information
- Market capitalization: $189499015168
- P/E ratio: 33.3976
- PEG ratio: 5.9854
- Dividend yield: 0.0201%
Get more detailed information and learn how to buy ABT.US stock
Company summary
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Historical performance
Stock information
- Market capitalization: $348092694528
- P/E ratio: 27.7788
- PEG ratio: 0.8879
- Dividend yield: 0.0323%
Get more detailed information and learn how to buy JNJ.US stock
Company summary
Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Historical performance
Stock information
- Market capitalization: $12340033536
- P/E ratio: 85.4545
- Dividend yield: N/A%
Get more detailed information and learn how to buy SWAV.US stock

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

1 - 6 of 6

Name	Ratings	Available asset types	Minimum deposit	Stock trade fee	Cash sweep APY	Signup bonus
SoFi Invest® Finder Score: 4.2 / 5: ★★★★★ SoFi Invest® Finder Score: 4.2 / 5: ★★★★★	★★★★★	Stocks, Mutual funds, ETFs, Alternatives	$0	$0		Get up to $1,000 in stock when you fund a new Active Invest account	Go to site More Info		loading Fetching your data...
Tastytrade Finder Score: 4.6 / 5: ★★★★★ Tastytrade Finder Score: 4.6 / 5: ★★★★★	★★★★★	Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills	$0	$0	N/A	Get $100-$5,000 when you open and fund an account with $5,000 to $1,000,000+	Highly commended for Best Derivatives Trading Platform award.	Go to site More Info		loading Fetching your data...
Public.com Finder Score: 4.1 / 5: ★★★★★ Public.com Finder Score: 4.1 / 5: ★★★★★	★★★★★	Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles	$0	$0	5.1%	N/A	2.5% fee applies to all alternative asset transactions.	Go to site More Info		loading Fetching your data...
Robinhood Gold Finder Score: 4.3 / 5: ★★★★★ Robinhood Gold Finder Score: 4.3 / 5: ★★★★★	★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	5%	Get a free stock when you successfully sign up and link your bank account.	Try Robinhood Gold for 30 days risk-free upon signup and earn a 5% APY on your uninvested cash, a 3% match on IRA contributions, up to $50,000 in instant deposits and more. Accounts are auto-downgraded after the trial period.	Go to site More Info		loading Fetching your data...
Moomoo Finder Score: 4.7 / 5: ★★★★★ Moomoo Finder Score: 4.7 / 5: ★★★★★ Exclusive	★★★★★	Stocks, Options, ETFs	$0	$0	5.10%	Choose a 1.5% match or 7 free fractional shares when you open a new account and meet funding requirements	No commission stock and ETF trading, with a chance to get a 1.5% cash reward match or 7 free fractional shares.	Go to site More Info		loading Fetching your data...
Robinhood Finder Score: 4.3 / 5: ★★★★★ Robinhood Finder Score: 4.3 / 5: ★★★★★	★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	1.5%, or 5% with Robinhood Gold	Get a free stock when you successfully sign up and link your bank account.	Try Robinhood Gold for 30 days risk-free upon signup and earn a 5% APY on your uninvested cash, a 3% match on IRA contributions, up to $50,000 in instant deposits and more. Accounts are auto-downgraded after the trial period.	Go to site More Info		loading Fetching your data...

loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

More on investing

How to buy FAANG stocks

Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.

Read more…

How to buy soccer stocks

A simple guide to buying stocks in your favorite European soccer team.

Read more…

Inflation stocks

Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.

Read more…

Thank you for your feedback!

Dawn Daniels

Dawn Daniels is a freelance content strategist and SEO manager and former editor at Finder, specializing in investments and lending. Dawn has edited more than 50 published books, including personal finance titles that have become best sellers on the Amazon Top 100. She holds a BA in English language and literature from Cornell College.

How to buy Virios Therapeutics stock How to buy GeoVax Labs stock

More guides on Finder

GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
10 best brokerage account bonuses of 2024
Explore the best bonuses for opening a new brokerage account.
11 best trading platforms for beginners 2024
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Methodology for robo-advisors
We rate robo-advisors across eight key categories, including ongoing costs, minimum deposit requirements, portfolio mix and more.
Public.com review 2024
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
SoFi Invest® review 2024
SoFi is a commission-free platform with both active and automated investment accounts.
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
Charles Schwab review 2024
Take advantage of $0 trades and no investment minimums with this well-known broker.
Robinhood review 2024
A deep dive into the highlights and limitations of Robinhood.

Ask a Question

Click here to cancel reply.

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

How to buy Spinal Elements (SPEL) stock when it goes public

Here's everything we know so far about the Spinal Elements IPO.

What we know about the Spinal Elements IPO

How to buy Spinal Elements stock when it starts trading